Biossom Investment Management

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 1, 2017	CANbridge Pharmaceuticals	$25.0M Series B	Lapam Capital	Qiming Venture Partners, Haoyue Capital, WuXi AppTec, Yanyuan Capital, YuanMing Capital

Total Raised

N/A

Valuation

N/A